Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 6/12/25 → 6/12/27 |
Funding
- Sanofi Pasteur Incorporated: $35,000.00
PSK05: A Phase 3, Randomized, Modified Double-Blind, Active-Controlled, Parallel-Group, 2-Arm Study to Investigate the Safety of a 4-Dose Regimen of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
- Wurth, Mark (PI)
- Davies, Theresa (CoI)
- Howard, Joel (CoI)